Wednesday 17th August 2022 |
Text too small? |
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under one or more of FPH’s employee share plans.
This notice is given in reliance on a waiver from NZX Listing Rule 3.13.1 granted by NZX on 6 August 2019 that allows FPH, subject to certain conditions, to disclose the issue of FPH shares under FPH’s employee share plans within 10 business days of issue.
Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Ordinary shares
ISIN NZFAPE0001S2
Section 2: capital change details
Number of issuances to which this notice relates Eight
Number issued
(1) 2,366
(2) 4,643
(3) 1,504
(4) 559
(5) 3,677
(6) 1,349
(7) 4,428
(8) 1,349
Total issued: 19,875 shares
Nominal value (if any) Not applicable
Issue price
(1) 11.81NZD (1,260 shares); 14.91NZD (1,106 shares)
(2) 11.81NZD
(3) 11.81NZD
(4) 11.81NZD
(5) 11.81NZD
(6) 11.81NZD
(7) 11.81NZD
(8) 11.81NZD
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued
(1) 0.00041%
(2) 0.00080%
(3) 0.00026%
(4) 0.00010%
(5) 0.00064%
(6) 0.00023%
(7) 0.00077%
(8) 0.00023%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue
(1) Exercise of 1,260 options and issue of 1,260 ordinary shares; cancellation of 3,669 options and issue of 1,106 ordinary shares under the FPH Share Option Plan.
(2) Cancellation of 10,351 options and issue of 4,643 ordinary shares.
(3) Cancellation of 3,352 options and issue of 1,504 ordinary shares.
(4) Cancellation of 1,301 options and issue of 559 ordinary shares.
(5) Cancellation of 8,469 options and issue of 3,677 ordinary shares.
(6) Cancellation of 3,021 options and issue of 1,349 ordinary shares.
(7) Cancellation of 9,783 options and issue of 4,428 ordinary shares.
(8) Cancellation of 3,032 options and issue of 1,349 ordinary shares.
All cancellations are under the FPH Share Option Plan Cancellation Facility
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue.
(1) Total number (excluding Treasury Stock): 577,340,067.
Treasury stock: 137,282
(2) Total number (excluding Treasury Stock): 577,344,710.
Treasury stock: 137,282
(3) Total number (excluding Treasury Stock): 577,346,214.
Treasury stock: 137,282
(4) Total number (excluding Treasury Stock): 577,346,773.
Treasury stock: 137,282
(5) Total number (excluding Treasury Stock): 577,350,450.
Treasury stock: 137,282
(6) Total number (excluding Treasury Stock): 577,351,799.
Treasury stock: 137,282
(7) Total number (excluding Treasury Stock): 577,356,227.
Treasury stock: 137,282
(8) Total number (excluding Treasury Stock): 577,357,576.
Treasury stock: 137,282
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (excluding Treasury Stock): 577,357,576.
Treasury stock as at the date of this notice: 137,282.
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (including Treasury Stock): 577,494,858.
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution, Listing Rule 4.6
Terms or details of the issue The ordinary shares issued rank pari passu with the existing ordinary shares
Date of issue
(1) 04 August 2022
(2) 05 August 2022
(3) 08 August 2022
(4) 09 August 2022
(5) 10 August 2022
(6) 11 August 2022
(7) 15 August 2022
(8) 17 August 2022
Section 3: authority for this announcement
Name of person authorised to make this announcement
Raelene Leonard
Contact phone number +64 9 574 0147
Contact email address raelene.leonard@fphcare.co.nz
Date of release via MAP 17 August 2022
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b